
Sorriso Pharmaceuticals
Developer of disease-modifying antibodies designed for the treatment of inflammatory diseases, including Crohn's disease and ulcerative colitis. The company develops potent antibodies that can be deli...
Valuation
$0
Share Price
N/A
Total Raised
$31M
Last Round
N/A